Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction

Toshikazu Takabatake,Hiromichi Ohta,Yoshiharu Yamamoto,Y. Ishida,Hiromoto Hara,Yasuyuki Ushiogi,S. Nakamura,Naoteru Hashimoto,Tohru Sasaki,Shigehiko Satoh,Y. Yamada,K. Ohta,Takuyuki Ise,Kenichi Kobayashi

Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction

1991

Toshikazu Takabatake
Hiromichi Ohta
Yoshiharu Yamamoto
Y. Ishida
Hiromoto Hara
Yasuyuki Ushiogi
S. Nakamura
Naoteru Hashimoto
Tohru Sasaki
Shigehiko Satoh
Y. Yamada
K. Ohta
Takuyuki Ise
Kenichi Kobayashi

The pharmacokinetics of a new Class I antiarrhythmic agent, SUN 1165, has been studied in 32 patients with varying degrees of renal impairment following a single oral dose of 50 mg.

Keywords:

Anesthesia
Antiarrhythmic agent
Diabetes mellitus
Oral administration
Medicine
Pharmacokinetics
Pharmacology
single oral dose
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations